Astrid Zedlitz Johansen

department of oncology copenhagen university hospital–herlev and gentofte herlev denmark

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Lars Grøntved

University of Southern Denmark

DENMARK

View details

Mirna Perez-Moreno

Københavns Universitet

DENMARK

View details

Birgitte Regenberg

DENMARK

View details

Julia Johansen

Professor

Copenhagen University Hospital

DENMARK

View details

Ole Thorlacius-Ussing

Aalborg University

DENMARK

View details

Christina Ankjærgaard

Technical University of Denmark

DENMARK

View details

Christian Beltoft Brøchner

Københavns Universitet

DENMARK

View details

Daniel Hargboel Madsen

Associate Professor

University of Copenhagen

DENMARK

View details

Søren Lundbye-Christensen

Aalborg University

DENMARK

View details

Sidsel Christy Lindgaard

Københavns Universitet

DENMARK

View details

Jessica Xin Hjaltelin

Associate Professor

University of Copenhagen

DENMARK

View details

Kirstine Kloeve-Mogensen

Aalborg University

DENMARK

View details

Benjamin Emil Stubbe

Aalborg University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Astrid Zedlitz Johansen

Research Interests

Explore related searches

Contact this professor

Articles (10)

Dissecting tumor microenvironment heterogeneity in syngeneic mouse models

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma

Variation of extrachromosomal circular DNA in cancer cell lines

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy

High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma

Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer

Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy

Collaborators (13)

Lars Grøntved

Mirna Perez-Moreno

Birgitte Regenberg

Julia Johansen

Ole Thorlacius-Ussing

Christina Ankjærgaard

Christian Beltoft Brøchner

Daniel Hargboel Madsen

Søren Lundbye-Christensen

Sidsel Christy Lindgaard

Jessica Xin Hjaltelin

Kirstine Kloeve-Mogensen

Benjamin Emil Stubbe

Make your next move.